S&P 500   5,137.08 (+0.80%)
DOW   39,087.38 (+0.23%)
QQQ   445.61 (+1.51%)
AAPL   179.66 (-0.60%)
MSFT   415.50 (+0.45%)
META   502.30 (+2.48%)
GOOGL   137.14 (-0.95%)
AMZN   178.22 (+0.83%)
TSLA   202.64 (+0.38%)
NVDA   822.79 (+4.00%)
NIO   5.77 (+0.35%)
AMD   202.64 (+5.25%)
BABA   74.63 (+0.81%)
T   17.00 (+0.41%)
F   12.45 (+0.08%)
MU   95.15 (+5.01%)
CGC   3.21 (-2.43%)
GE   158.67 (+1.13%)
DIS   111.93 (+0.31%)
AMC   4.36 (+0.93%)
PFE   26.58 (+0.08%)
PYPL   60.54 (+0.33%)
XOM   105.78 (+1.21%)
S&P 500   5,137.08 (+0.80%)
DOW   39,087.38 (+0.23%)
QQQ   445.61 (+1.51%)
AAPL   179.66 (-0.60%)
MSFT   415.50 (+0.45%)
META   502.30 (+2.48%)
GOOGL   137.14 (-0.95%)
AMZN   178.22 (+0.83%)
TSLA   202.64 (+0.38%)
NVDA   822.79 (+4.00%)
NIO   5.77 (+0.35%)
AMD   202.64 (+5.25%)
BABA   74.63 (+0.81%)
T   17.00 (+0.41%)
F   12.45 (+0.08%)
MU   95.15 (+5.01%)
CGC   3.21 (-2.43%)
GE   158.67 (+1.13%)
DIS   111.93 (+0.31%)
AMC   4.36 (+0.93%)
PFE   26.58 (+0.08%)
PYPL   60.54 (+0.33%)
XOM   105.78 (+1.21%)
S&P 500   5,137.08 (+0.80%)
DOW   39,087.38 (+0.23%)
QQQ   445.61 (+1.51%)
AAPL   179.66 (-0.60%)
MSFT   415.50 (+0.45%)
META   502.30 (+2.48%)
GOOGL   137.14 (-0.95%)
AMZN   178.22 (+0.83%)
TSLA   202.64 (+0.38%)
NVDA   822.79 (+4.00%)
NIO   5.77 (+0.35%)
AMD   202.64 (+5.25%)
BABA   74.63 (+0.81%)
T   17.00 (+0.41%)
F   12.45 (+0.08%)
MU   95.15 (+5.01%)
CGC   3.21 (-2.43%)
GE   158.67 (+1.13%)
DIS   111.93 (+0.31%)
AMC   4.36 (+0.93%)
PFE   26.58 (+0.08%)
PYPL   60.54 (+0.33%)
XOM   105.78 (+1.21%)
S&P 500   5,137.08 (+0.80%)
DOW   39,087.38 (+0.23%)
QQQ   445.61 (+1.51%)
AAPL   179.66 (-0.60%)
MSFT   415.50 (+0.45%)
META   502.30 (+2.48%)
GOOGL   137.14 (-0.95%)
AMZN   178.22 (+0.83%)
TSLA   202.64 (+0.38%)
NVDA   822.79 (+4.00%)
NIO   5.77 (+0.35%)
AMD   202.64 (+5.25%)
BABA   74.63 (+0.81%)
T   17.00 (+0.41%)
F   12.45 (+0.08%)
MU   95.15 (+5.01%)
CGC   3.21 (-2.43%)
GE   158.67 (+1.13%)
DIS   111.93 (+0.31%)
AMC   4.36 (+0.93%)
PFE   26.58 (+0.08%)
PYPL   60.54 (+0.33%)
XOM   105.78 (+1.21%)

Ensysce Biosciences (ENSC) Short Interest Ratio & Short Volume

$0.92
-0.01 (-1.07%)
(As of 03/1/2024 ET)

Ensysce Biosciences Short Interest Data

Current Short Volume
61,100 shares
Previous Short Volume
678,500 shares
Change Vs. Previous Month
-90.99%
Dollar Volume Sold Short
$54,379.00
Short Interest Ratio / Days to Cover
0.0
Last Record Date
February 15, 2024
Outstanding Shares
3,150,000 shares
Float Size
2,910,000 shares
Short Percent of Float
2.10%
Today's Trading Volume
196,998 shares
Average Trading Volume
2,141,855 shares
Today's Volume Vs. Average
9%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Ensysce Biosciences ?

Sign up to receive the latest short interest report for Ensysce Biosciences and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

ENSC Short Interest Over Time

ENSC Days to Cover Over Time

ENSC Percentage of Float Shorted Over Time


Ensysce Biosciences Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
2/15/202461,100 shares $54,379.00 -91.0%2.1%0 $0.89
1/31/2024678,500 shares $1.10 million +175.5%23.3%0.5 $1.62
1/15/2024246,300 shares $337,431.00 +9.1%8.8%0.2 $1.37
12/31/2023225,700 shares $239,242.00 +35.2%8.0%1 $1.06
12/15/2023167,000 shares $185,370.00 +25.3%5.9%0.8 $1.11
11/30/2023133,300 shares $151,962.00 +96.6%4.8%0.9 $1.14
11/15/202367,800 shares $59,806.38 +11.3%2.4%0.9 $0.88
10/31/202360,900 shares $56,094.99 +161.4%2.2%0.8 $0.92
10/15/202323,300 shares $33,552.00 +9.9%0.9%0.3 $1.44
9/30/202321,200 shares $29,256.00 -20.0%0.8%0.4 $1.38
9/15/202326,500 shares $46,375.00 -4.0%1.1%0.1 $1.75
8/31/202327,600 shares $51,060.00 -2.1%1.1%0.1 $1.85
8/15/202328,200 shares $54,990.00 -36.8%1.0%0.1 $1.95
7/31/202344,600 shares $89,646.00 +81.3%1.9%0.1 $2.01
7/15/202324,600 shares $48,216.00 +24.9%1.4%0 $1.96
6/30/202319,700 shares $36,051.00 -2.5%2.4%0 $1.83
6/15/202320,200 shares $47,470.00 +6.3%2.5%0 $2.35
5/31/202319,000 shares $45,030.00 -83.3%2.3%0 $2.37
5/15/2023113,600 shares $349,888.00 +43.8%11.0%0.2 $3.08
4/30/202379,000 shares $296,250.00 +62.2%6.3%0.1 $3.75
4/15/202348,700 shares $194,366.57 +5.9%3.9%0.2 $3.99
3/31/202346,000 shares $2.68 million -92.1%6.9%0.2 $58.32
3/15/2023580,700 shares $351,904.20 +194.3%17.3%0.3 $0.61
2/28/2023197,300 shares $96,479.70 -28.3%5.7%0.1 $0.49
2/15/2023275,200 shares $167,872.00 -47.6%7.2%0.1 $0.61
1/31/2023525,000 shares $367,500.00 +631.2%9.9%0.2 $0.70
1/15/202371,800 shares $55,321.90 -9.9%1.6%0 $0.77
12/30/202279,700 shares $59,775.00 -44.4%1.7%0.1 $0.75
12/15/2022143,400 shares $131,340.06 -54.6%7.1%0.1 $0.92
11/30/2022315,700 shares $915,530.00 +128.9%17.3%0.3 $2.90
11/15/2022137,900 shares $297,864.00 -8.1%7.5%0.2 $2.16
10/31/2022150,000 shares $484,500.00 -78.5%10.1%0.8 $3.23
10/15/2022698,700 shares $144,630.90 -39.8%3.2%0.5 $0.21
9/30/20221,160,000 shares $249,400.00 -27.5%5.3%1.1 $0.22
9/15/20221,600,000 shares $551,840.00 +134.6%7.4%1 $0.34
8/31/2022681,900 shares $288,034.56 -5.0%3.3%0.5 $0.42
8/15/2022717,500 shares $350,211.75 +30.6%3.5%0.6 $0.49
7/31/2022549,200 shares $282,783.08 -12.1%2.9%0.5 $0.51
7/15/2022624,900 shares $365,628.99 +20.0%3.3%0.5 $0.59
6/30/2022520,600 shares $452,089.04 +45.0%2.9%0.4 $0.87













ENSC Short Interest - Frequently Asked Questions

What is Ensysce Biosciences' current short interest?

Short interest is the volume of Ensysce Biosciences shares that have been sold short but have not yet been covered or closed out. As of February 15th, traders have sold 61,100 shares of ENSC short. 2.10% of Ensysce Biosciences' shares are currently sold short. Learn More on Ensysce Biosciences' current short interest.

Which institutional investors are shorting Ensysce Biosciences?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Ensysce Biosciences: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for Ensysce Biosciences?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.10% of Ensysce Biosciences' floating shares are currently sold short.

Is Ensysce Biosciences' short interest increasing or decreasing?

Ensysce Biosciences saw a decline in short interest during the month of February. As of February 15th, there was short interest totaling 61,100 shares, a decline of 91.0% from the previous total of 678,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Ensysce Biosciences' float size?

Ensysce Biosciences currently has issued a total of 3,150,000 shares. Some of Ensysce Biosciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Ensysce Biosciences currently has a public float of 2,910,000 shares.

How does Ensysce Biosciences' short interest compare to its competitors?

2.10% of Ensysce Biosciences' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Ensysce Biosciences: Aptevo Therapeutics Inc. (0.10%), Processa Pharmaceuticals, Inc. (7.72%), Altamira Therapeutics Ltd. (3.82%), InMed Pharmaceuticals Inc. (2.28%), Clearmind Medicine Inc. (5.98%), Jaguar Health, Inc. (9.78%), Aravive, Inc. (1.81%), LumiraDx Limited (2.89%), Qualigen Therapeutics, Inc. (0.62%), Salarius Pharmaceuticals, Inc. (0.15%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Super Micro Computer, Inc. ($5.32 billion), T-Mobile US, Inc. ($4.38 billion), General Motors ($3.76 billion), Occidental Petroleum Co. ($3.08 billion), Charter Communications, Inc. ($2.65 billion), Coinbase Global, Inc. ($2.62 billion), Tractor Supply ($2.52 billion), Moderna, Inc. ($2.19 billion), Rivian Automotive, Inc. ($1.84 billion), and Royal Caribbean Cruises Ltd. ($1.78 billion). View all of the most shorted stocks.

What does it mean to sell short Ensysce Biosciences stock?

Short selling ENSC is an investing strategy that aims to generate trading profit from Ensysce Biosciences as its price is falling. ENSC shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Ensysce Biosciences?

A short squeeze for Ensysce Biosciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ENSC, which in turn drives the price of the stock up even further.

How often is Ensysce Biosciences' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ENSC, twice per month. The most recent reporting period available is February, 15 2024.



More Short Interest Resources from MarketBeat

This page (NASDAQ:ENSC) was last updated on 3/1/2024 by MarketBeat.com Staff